BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15791439)

  • 21. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 22. 99mTc-M-TRODAT is not superior to (99m)Tc-TRODAT-1 for the diagnosis of Parkinson's disease.
    Maes A; Vanbilloen H; Cleynhens B; Mortelmans L; Bormans G; Verbruggen A
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):796-7. PubMed ID: 12618905
    [No Abstract]   [Full Text] [Related]  

  • 23. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
    J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine transporter binding in smokers and nonsmokers.
    Newberg A; Lerman C; Wintering N; Ploessl K; Mozley PD
    Clin Nucl Med; 2007 Jun; 32(6):452-5. PubMed ID: 17515751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.
    Van Laere K; Santens P; Bosman T; De Reuck J; Mortelmans L; Dierckx R
    J Nucl Med; 2004 Jun; 45(6):933-42. PubMed ID: 15181127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson's disease patients.
    Tsuchida T; Ballinger JR; Vines D; Kim YJ; Utsunomiya K; Lang AE; Ichise M
    Ann Nucl Med; 2004 Oct; 18(7):609-16. PubMed ID: 15586635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography.
    Bao SY; Wu JC; Luo WF; Fang P; Liu ZL; Tang J
    J Neuroimaging; 2000 Oct; 10(4):200-3. PubMed ID: 11147397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
    Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
    Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
    Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
    J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
    Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
    J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.
    Bosman T; Van Laere K; Santens P
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):16-24. PubMed ID: 12483405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
    Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
    Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease.
    Chou KL; Hurtig HI; Stern MB; Colcher A; Ravina B; Newberg A; Mozley PD; Siderowf A
    Parkinsonism Relat Disord; 2004 Aug; 10(6):375-9. PubMed ID: 15261880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
    Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
    Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
    Dresel SH; Kung MP; Plössl K; Meegalla SK; Kung HF
    Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease.
    Acton PD; Mozley PD; Kung HF
    Eur J Nucl Med; 1999 Nov; 26(11):1413-23. PubMed ID: 10552082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.